Investor profile
Sofinnova Capital IX
Sofinnova Partners SAS · Multi-Country
Investment focus
Start with the fit.
Sofinnova Capital IX is a life-sciences fund managed by Sofinnova Partners, a Paris-based venture firm specialised in healthcare. The fund closed oversubscribed at EUR 333M (2019) and invests in early-stage biopharmaceutical and medical-device companies, mainly across Europe with some exposure to North America.
EUACC Intelligence
Free preview
EUACC Intelligence
Research Sofinnova Capital IX
Explore the record and prepare questions for the fund.
Your side of the introduction
List your startup →